# Bristol-Myers Squibb Company (BMY) — Q2-2021 Earnings Results

**Report date:** 2021-07-28 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2021

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 1.84%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.93 | N/A | +2.77% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their strategic initiatives. They are focused on sustaining growth through innovation.

**Key quotes:**

> Management highlighted ongoing progress in their pipeline.

> They emphasized the importance of their recent product launches.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, indicating stronger-than-expected profitability. The stock reacted positively, rising by 1.84%, likely driven by management's confidence in their product pipeline and growth strategy. However, the lack of revenue data and guidance leaves some uncertainty for investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2021_